ResearcherGuiyang Medical UniversityNo recent work listed
Chengyi Sun
Matched on ORCID iD 0000-0001-8500-1878; OpenAlex author ID A5052343893. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2014: 1 paper · 2015: 2 papers · 2016: 2 papers
Papers 5
- Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer. First author DOI 10.1007/s13277-016-5217-5↗
- Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis. Last author DOI 10.5301/jbm.5000172↗
- MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Last author DOI 10.1016/j.canlet.2014.11.007↗
- Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in huma… Co-author DOI 10.1016/j.canlet.2014.11.026↗
- MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3. Last author DOI 10.1007/s13277-014-2271-8↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianxin Jiang · 4 shared papers, 2014–2016 · strength 0.22
- Paper Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer. DOI 10.1007/s13277-016-5217-5↗
- Paper MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. DOI 10.1016/j.canlet.2014.11.007↗
- Paper Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inac… DOI 10.1016/j.canlet.2014.11.026↗
- Chao Yu · 3 shared papers, 2014–2016 · strength 0.17
- Paper Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer. DOI 10.1007/s13277-016-5217-5↗
- Paper MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. DOI 10.1016/j.canlet.2014.11.007↗
- Paper MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3. DOI 10.1007/s13277-014-2271-8↗
- She Tian · 2 shared papers, 2016 · strength 0.14
- Meiyuan Chen · 2 shared papers, 2015–2016 · strength 0.13
- Hao Zhang · 1 shared paper, 2016 · strength 0.07
- Yaozhen Pan · 1 shared paper, 2016 · strength 0.07
- Huajian Gu · 1 shared paper, 2016 · strength 0.07
- Xin Wang · 1 shared paper, 2015 · strength 0.04
- Xu Li · 1 shared paper, 2015 · strength 0.04
- Xingjun Guo · 1 shared paper, 2015 · strength 0.04
- Chengjian Shi · 1 shared paper, 2015 · strength 0.04
- Renyi Qin · 1 shared paper, 2015 · strength 0.04
- Li Xu · 1 shared paper, 2014 · strength 0.04
- Zhipeng Li · 1 shared paper, 2014 · strength 0.04
- Min Wang · 1 shared paper, 2014 · strength 0.04
- Jie Xiao · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.